ADA26: Survodutide's liver promise overshadowed by high dropout rates
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
Survodutide is showing promise for liver health, but its potential is being overshadowed by issues with high dropout rates. The treatment's effectiveness is being reported alongside concerns about its ability to retain participants. The impact of these dropout rates on the overall assessment of survodutide is unclear.